These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19149079)

  • 1. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
    Ozkütük N; Ecemiş T; Sürücüoğlu S
    Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
    Aragón LM; Garrigó M; Moreno C; Español M; Coll P
    J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
    Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
    Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P; Tansel O
    New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
    Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.
    Hannan MM; Desmond EP; Morlock GP; Mazurek GH; Crawford JT
    J Clin Microbiol; 2001 Feb; 39(2):647-50. PubMed ID: 11158123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
    Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
    Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
    Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
    Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis.
    Zimhony O; Cox JS; Welch JT; Vilchèze C; Jacobs WR
    Nat Med; 2000 Sep; 6(9):1043-7. PubMed ID: 10973326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec.
    Yee DP; Menzies D; Brassard P
    Int J Tuberc Lung Dis; 2012 May; 16(5):604-9. PubMed ID: 22409887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
    Coban AY; Bilgin K; Akgüneş A; Durupinar B
    Mikrobiyol Bul; 2008 Jul; 42(3):477-81. PubMed ID: 18822892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
    Syre H; Valvatne H; Sandven P; Grewal HM
    J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
    Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
    Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance rates to antituberculous drugs in Sivas province].
    Gönlügür U; Bakici MZ; Gönlügür TE; Hasbek M
    Mikrobiyol Bul; 2007 Jul; 41(3):459-63. PubMed ID: 17933259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
    Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.